Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Charles

Showing results (811-820 of 886) with videos related to

Pageof 89
Sort By:
Clinical and Vaccine Immunology : CVI|March 25, 2016
O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in BangladeshAmena Aktar, M Arifur Rahman, Sadia Afrin, et al.
Cell|January 7, 2021
COVID-19-neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Nature Medicine|February 16, 2021
Humoral signatures of protective and pathological SARS-CoV-2 infection in childrenYannic C Bartsch, Chuangqi Wang, Tomer Zohar, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2020
COVID-19 neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Plos Neglected Tropical Diseases|April 7, 2018
Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteersKamrul Islam, Motaher Hossain, Meagan Kelly, et al.
Clinical and Vaccine Immunology : CVI|March 22, 2013
Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in BangladeshDaniel T Leung, Taher Uddin, Peng Xu, et al.
Plos Neglected Tropical Diseases|August 13, 2013
Identification of immunogenic Salmonella enterica serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, NepalRichelle C Charles, Tania Sultana, Mohammad Murshid Alam, et al.
Msphere|July 7, 2021
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139Mohammad Kamruzzaman, Meagan Kelly, Richelle C Charles, et al.
Msphere|July 15, 2026
Effects of improved water, sanitation, handwashing, and nutrition on early childhood IgG immune repertoire development against <i>Shigella</i> and enteroinvasive <i>Escherichia coli</i> (EIEC)Nikolina Walas, Everlyn Kamau, Minlu Zhang, et al.
Mbio|October 26, 2022
Identifying Recent Cholera Infections Using a Multiplex Bead Serological AssayForrest K Jones, Taufiqur R Bhuiyan, Rachel E Muise, et al.
Pageof 89

Showing results (811-820 of 886) with videos related to

Sort By:
Pageof 89
Clinical and Vaccine Immunology : CVI|March 25, 2016
O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in BangladeshAmena Aktar, M Arifur Rahman, Sadia Afrin, et al.
Cell|January 7, 2021
COVID-19-neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Nature Medicine|February 16, 2021
Humoral signatures of protective and pathological SARS-CoV-2 infection in childrenYannic C Bartsch, Chuangqi Wang, Tomer Zohar, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2020
COVID-19 neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Plos Neglected Tropical Diseases|April 7, 2018
Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteersKamrul Islam, Motaher Hossain, Meagan Kelly, et al.
Clinical and Vaccine Immunology : CVI|March 22, 2013
Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in BangladeshDaniel T Leung, Taher Uddin, Peng Xu, et al.
Plos Neglected Tropical Diseases|August 13, 2013
Identification of immunogenic Salmonella enterica serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, NepalRichelle C Charles, Tania Sultana, Mohammad Murshid Alam, et al.
Msphere|July 7, 2021
Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139Mohammad Kamruzzaman, Meagan Kelly, Richelle C Charles, et al.
Msphere|July 15, 2026
Effects of improved water, sanitation, handwashing, and nutrition on early childhood IgG immune repertoire development against <i>Shigella</i> and enteroinvasive <i>Escherichia coli</i> (EIEC)Nikolina Walas, Everlyn Kamau, Minlu Zhang, et al.
Mbio|October 26, 2022
Identifying Recent Cholera Infections Using a Multiplex Bead Serological AssayForrest K Jones, Taufiqur R Bhuiyan, Rachel E Muise, et al.
Pageof 89